Source: Virtual Congress 2020 – Translational therapeutic advances



Rating:

Share or cite this content

Citations should be made in the following way:
M. Camprubí-Rimblas (Sabadell, Spain), A. Areny (Sabadell, Spain), R. Guillamat-Prats (Sabadell, Spain), L. Morales-Quinteros (Sabadell, Spain), N. Tantinyà (Sabadell, Spain), J. Bringué (Sabadell, Spain), L. Blanch (Sabadell, Spain), A. Artigas (Sabadell, Spain). Combined cell therapy and anticoagulants for acute respiratory distress syndrome. 3347

Member's Comments

No comment yet.

Related content which might interest you: Corticosteroids in acute respiratory distress syndrome Source: Virtual Congress 2021 – Respiratory critical care Year: 2021 Severe acute respiratory distress syndrome due to ipilimumab Source: Eur Respir J 2013; 42: 866-868 Year: 2013 Early intervention with non-invasive respiratory therapies in mild acute respiratory distress syndrome secondary to COVID-19 Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19 Year: 2021 Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome Source: Eur Respir J 2003; 21: 720-727 Year: 2003 Therapeutic targeting of metabolic alterations in acute respiratory distress syndrome Source: Eur Respir Rev, 29 (156) 200114; 10.1183/16000617.0114-2020 Year: 2020 Prognosis of acute respiratory distress syndrome in neutropenic cancer patients Source: Eur Respir J 2012; 40: 169-176 Year: 2012 Corticosteroids and acute respiratory distress syndrome (ARDS) Source: Annual Congress 2007 - Corticosteroids and respiratory failure Year: 2007 Acute increase in KL-6/MUC1 mucin as a potential trigger of disseminated intravascular coagulation in acute respiratory distress syndrome Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management Year: 2006 Current invasive ventilatory strategies in acute respiratory distress syndrome Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=161 Year: 2002 Surfactant therapy in acute lung injury/acute respiratory distress syndrome Source: Eur Respir Mon 2012; 55: 54-64 Year: 2012 Early corticosteroid in influenza pneumonia related acute respiratory distress syndrome treated with extracorporeal membrane oxygenation Source: International Congress 2018 – Preclinical and clinical studies of critical illness Year: 2018 Pathogenesis of acute microvascular lung injury and the acute respiratory distress syndrome Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=22 Year: 2002 Exogenous pulmonary surfactant administration for acute respiratory distress syndrome in post-operative patients Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009 Phenotypes of acute respiratory distress syndrome Source: Virtual Congress 2021 – Respiratory critical care Year: 2021 Progress and potential of mesenchymal stromal cell therapy in acute respiratory distress syndrome Source: Eur Respir Monogr 2021; 91: 353-372 Year: 2021 Ventilatory management in acute respiratory failure of patients with obesity-hypoventilation syndrome Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Pneumonectomy subjects with acute respiratory distress syndrome: what to do Source: Eur Respir Rev 2015; 24: 154 Year: 2015 Acute respiratory distress syndrome Source: Eur Respir Rev, 26 (144) 160116; 10.1183/16000617.0116-2016 Year: 2017 Acute respiratory distress syndrome  Source: International Congress 2017 – State of the art session: "Acute and chronic respiratory failure and sleep" Year: 2017 Acute respiratory distress syndrome Source: International Congress 2016 – Clinical year in review Year: 2016